ArticleCellular and molecular life sciences : CMLS2025

Portal venous circulating tumor cells as a biomarker for relapse prediction in resected pancreatic cancer.

Dannel Yeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.